The main indication for medical treatment of the secretory pituitary adenom
as is macroprolactinoma. In this case, bromocriptine therapy obtains better
results than surgery, by a life-long administration. New dopaminergic drug
s with better tolerance and a longer half-life than bromocriptine will prob
ably improve compliance to treatment. Besides, somatostatin analogs, especi
ally the slowly-released preparations, administrated once or twice per mont
h, often obtain normalization of hormonal production in GH (growth hormone)
or TSH (thyrotropin) secreting adenomas after surgical failure and are use
d in complement to radiotherapy.